Robert Gaertner, Vice President of Quality Strategy Europe at Veeva Systems, discusses the growing importance of connected platforms in ensuring quality in pharmaceutical manufacturing and…
Winston Churchill once famously said; “Healthy citizens are the greatest asset any country can have.” The importance of a healthy population is why we see…
Regulatory workloads now far exceed the pace of company growth, but assigning more people to the tasks isn’t an option, which in turn is driving…
While AI in the pharma cold chain promises exciting possibilities, achieving these benefits is not a sprint but a marathon. The journey towards fully integrating…
The pharmaceutical industry plays a vital role in safeguarding public health. However, in recent years the public have played witness to a concerning rise in…
In the pharmaceutical industry, many rebate contract managers spend hundreds of hours manually identifying key data points from thousands of contracts. Rebate contracts can impact…
As Life Sciences companies comes to rely increasingly on digital capabilities and good data for efficiency and competitive advantage, it’s critical that they harness system…
Medical writing in pharma is ripe for disruption, across use cases linked to regulatory documentation and safety report summaries, and Generative AI (GenAI) promises exactly…
Companies are overcoming challenges to develop, launch, and educate on new rare disease medicines and treatment faster. Rare diseases are no longer rare. Every year,…
Drug research and development can cost up to $6bn per asset and take an average of 13 years from discovery to approval1. In this expensive…
